TY - JOUR
T1 - Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage
AU - Falcone, Guido J.
AU - Kirsch, Elayna
AU - Acosta, Julian N.
AU - Noche, Rommell B.
AU - Leasure, Audrey
AU - Marini, Sandro
AU - Chung, Jaeyoon
AU - Selim, Magdy
AU - Meschia, James F.
AU - Brown, Devin L.
AU - Worrall, Bradford B.
AU - Tirschwell, David L.
AU - Jagiella, Jeremiasz M.
AU - Schmidt, Helena
AU - Jimenez-Conde, Jordi
AU - Fernandez-Cadenas, Israel
AU - Lindgren, Arne
AU - Slowik, Agnieszka
AU - Gill, Dipender
AU - Holmes, Michael
AU - Phuah, Chia Ling
AU - Petersen, Nils H.
AU - Matouk, MD, Charles N.
AU - Gunel, Murat
AU - Sansing, Lauren
AU - Bennett, Derrick
AU - Chen, Zhengming
AU - Sun, Luan L.
AU - Clarke, Robert
AU - Walters, Robin G.
AU - Gill, Thomas M.
AU - Biffi, Alessandro
AU - Kathiresan, Sekar
AU - Langefeld, Carl D.
AU - Woo, Daniel
AU - Rosand, Jonathan
AU - Sheth, Kevin N.
AU - Anderson, Christopher D.
N1 - Publisher Copyright:
© 2020 American Neurological Association
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Objective: Observational studies point to an inverse correlation between low-density lipoprotein (LDL) cholesterol levels and risk of intracerebral hemorrhage (ICH), but it remains unclear whether this association is causal. We tested the hypothesis that genetically elevated LDL is associated with reduced risk of ICH. Methods: We constructed one polygenic risk score (PRS) per lipid trait (total cholesterol, LDL, high-density lipoprotein [HDL], and triglycerides) using independent genomewide significant single nucleotide polymorphisms (SNPs) for each trait. We used data from 316,428 individuals enrolled in the UK Biobank to estimate the effect of each PRS on its corresponding trait, and data from 1,286 ICH cases and 1,261 matched controls to estimate the effect of each PRS on ICH risk. We used these estimates to conduct Mendelian Randomization (MR) analyses. Results: We identified 410, 339, 393, and 317 lipid-related SNPs for total cholesterol, LDL, HDL, and triglycerides, respectively. All four PRSs were strongly associated with their corresponding trait (all p < 1.00 × 10-100). While one SD increase in the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0.85–0.99; p = 0.03) and LDL cholesterol (OR = 0.88; 95% CI = 0.81–0.95; p = 0.002) were inversely associated with ICH risk, no significant associations were found for HDL and triglycerides (both p > 0.05). MR analyses indicated that 1mmol/L (38.67mg/dL) increase of genetically instrumented total and LDL cholesterol were associated with 23% (OR = 0.77; 95% CI = 0.65–0.98; p = 0.03) and 41% lower risks of ICH (OR = 0.59; 95% CI = 0.42–0.82; p = 0.002), respectively. Interpretation: Genetically elevated LDL levels were associated with lower risk of ICH, providing support for a potential causal role of LDL cholesterol in ICH. ANN NEUROL 2020 ANN NEUROL 2020;88:56–66.
AB - Objective: Observational studies point to an inverse correlation between low-density lipoprotein (LDL) cholesterol levels and risk of intracerebral hemorrhage (ICH), but it remains unclear whether this association is causal. We tested the hypothesis that genetically elevated LDL is associated with reduced risk of ICH. Methods: We constructed one polygenic risk score (PRS) per lipid trait (total cholesterol, LDL, high-density lipoprotein [HDL], and triglycerides) using independent genomewide significant single nucleotide polymorphisms (SNPs) for each trait. We used data from 316,428 individuals enrolled in the UK Biobank to estimate the effect of each PRS on its corresponding trait, and data from 1,286 ICH cases and 1,261 matched controls to estimate the effect of each PRS on ICH risk. We used these estimates to conduct Mendelian Randomization (MR) analyses. Results: We identified 410, 339, 393, and 317 lipid-related SNPs for total cholesterol, LDL, HDL, and triglycerides, respectively. All four PRSs were strongly associated with their corresponding trait (all p < 1.00 × 10-100). While one SD increase in the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0.85–0.99; p = 0.03) and LDL cholesterol (OR = 0.88; 95% CI = 0.81–0.95; p = 0.002) were inversely associated with ICH risk, no significant associations were found for HDL and triglycerides (both p > 0.05). MR analyses indicated that 1mmol/L (38.67mg/dL) increase of genetically instrumented total and LDL cholesterol were associated with 23% (OR = 0.77; 95% CI = 0.65–0.98; p = 0.03) and 41% lower risks of ICH (OR = 0.59; 95% CI = 0.42–0.82; p = 0.002), respectively. Interpretation: Genetically elevated LDL levels were associated with lower risk of ICH, providing support for a potential causal role of LDL cholesterol in ICH. ANN NEUROL 2020 ANN NEUROL 2020;88:56–66.
UR - http://www.scopus.com/inward/record.url?scp=85085108436&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085108436&partnerID=8YFLogxK
U2 - 10.1002/ana.25740
DO - 10.1002/ana.25740
M3 - Article
C2 - 32277781
AN - SCOPUS:85085108436
SN - 0364-5134
VL - 88
SP - 56
EP - 66
JO - Annals of neurology
JF - Annals of neurology
IS - 1
ER -